
Sign up to save your podcasts
Or


In this episode, we discuss the P2Y12 inhibitors (clopidogrel, prasugrel, ticagrelor) and the role of dual antiplatelet therapy (DAPT) and triple oral antithrombotic therapy (TOAT).
By Sean P. Kane, PharmD; Khyati Patel, PharmD4.9
646646 ratings
In this episode, we discuss the P2Y12 inhibitors (clopidogrel, prasugrel, ticagrelor) and the role of dual antiplatelet therapy (DAPT) and triple oral antithrombotic therapy (TOAT).

43,307 Listeners

694 Listeners

499 Listeners

264 Listeners

3,343 Listeners

56,398 Listeners

1,157 Listeners

16,947 Listeners

402 Listeners

733 Listeners

299 Listeners

195 Listeners

516 Listeners

108 Listeners

155 Listeners